ITI Pharma and Healthcare Fund · Regular · Growth
NAV
₹17.9422
as of 31 Jul 2026
Expense Ratio
2.35%
AUM
₹234 Cr
Lumpsum returns (CAGR)
- 1Y
- +7.05%
- 3Y
- +18.12%
- 5Y
- —
- Since Inception
- +13.17%
SIP returns (XIRR)
- 1Y
- +22.26%
- 3Y
- +14.47%
- 5Y
- —
- Since Inception
- +16.60%
What history actually did — last 4 years (Aug 2022 – Jul 2026)
A ₹5,000 monthly SIP for the last 4 years (Aug 2022 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹3,24,431 today — ₹2,35,000 invested, 16.8% XIRR.
₹2,35,000
Invested
₹3,24,431
Value today
16.8%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 4 years (Aug 2022 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 4 years ago would be ₹1,95,581 today (18.3% CAGR).
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹3,24,431 in this fund vs ₹2,87,256 in the benchmark — outperformance of ₹37,175.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 4 years (Aug 2022 – Jul 2026) (3 Jun 2024) would be ₹1,35,459 today (1.35×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.08
Sharpe Ratio
+0.02
Alpha
0.22
Beta
0.07
Sortino
14.80%
Std Dev
-14.24%
Max Drawdown
Performance Comparison
Thinking about ITI Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Investment Objective
ITI Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹234 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.35%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations